Endocrinology AdvisorPCOS May Increase Risk for 4 Reproductive Cancers

ℹ️ Observational Association Only Evidence

A matched cohort of 422,613 women with PCOS and 2,113,065 without found PCOS was associated with markedly increased hazards across four reproductive cancers, most notably a nearly sixfold increase in uterine cancer risk (aHR 5.76) over a mean 3.6-year follow-up.

Clinical Considerations:

• PCOS was associated with increased hazards of breast cancer (aHR 2.66), ovarian/fallopian tube cancer (aHR 4.38), and cervical cancer (aHR 2.22), alongside the uterine cancer signal.
• E-values ranged from 3.87 to 11.00 across cancer types, suggesting findings were relatively robust to unmeasured confounding.
• Sensitivity analyses adjusting for comorbidity medications and restricting to ICD-coded PCOS diagnoses showed largely consistent results.
• Existing 2023 International PCOS Guidelines already recommend counseling on uterine cancer risk specifically, but this study extends the associated risk signal to three additional cancer types not yet addressed in that guidance.

Practice Applications:

• Recognize PCOS as a risk factor warranting reproductive cancer awareness beyond uterine cancer alone.
• Consider incorporating cancer-related counseling into routine PCOS visits.
• Avoid overstating causality given observational design and incomplete BMI and reproductive history data.
• Monitor emerging guidance as mechanistic research clarifies phenotypic risk variation.